Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value

$26.14−0.21 (-0.80%)

Close on Nov 13, 2026Market cap $1.00BP/E –Yield –

Earnings

Ceribell's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 23, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

$29.30M

+29.6% on a year earlier

EPS, Q3 FY2026

-$0.55

-$0.37 a year earlier

Latest guidance

Issued

Nov 3, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Ceribell's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 23, 2027Expected	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 3, 2026after the close	$29.30M	+29.6%	-$0.55	Release
Q2 FY2026ended Jun 30, 2026	Aug 10, 2026after the close	$28.10M	+32.5%	-$0.51	Release
Q1 FY2026ended Mar 31, 2026	May 11, 2026after the close	$26.50M	+29.3%	-$0.52	Release
Q4 FY2025ended Dec 31, 2025	Feb 24, 2026after the close	$24.80M	+34.1%	-$0.36	Release
Q3 FY2025ended Sep 30, 2025	Nov 4, 2025after the close	$22.60M	+31.4%	-$0.37	Release
Q2 FY2025ended Jun 30, 2025	Aug 5, 2025after the close	$21.20M	–	-$0.38	Release
Q1 FY2025ended Mar 31, 2025	May 8, 2025after the close	$20.50M	–	-$0.36	Release
Q4 FY2024ended Dec 31, 2024	Feb 25, 2025after the close	$18.50M	–	-$0.40	Release
Q3 FY2024ended Sep 30, 2024	Nov 12, 2024after the close	$17.20M	–	-$1.85	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Ceribell's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
growth	FY2026	+28% – +31%	–	New	Aug 10, 2026
revenue	FY2026	$115.00M – $117.00M	–	New	Nov 3, 2026
revenue	FY2026	$114.00M – $117.00M	$112.00M – $116.00M	Raised	Aug 10, 2026

Guidance vs results

The last range Ceribell gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue	$87.00M – $89.00M	$89.10MΣ4Q	Above range

Guidance history

Every forecast Ceribell put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 3, 2026	revenue	FY2026	$115.00M – $117.00M	New
Aug 10, 2026	growth	FY2026	+28% – +31%	New
Aug 10, 2026	revenue	FY2026	$114.00M – $117.00M	Raised
May 11, 2026	revenue guidance	FY2026	$112.00M – $116.00M	Raised
Feb 24, 2026	revenue	FY2026	$111.00M – $115.00M	New
Nov 4, 2025	growth	FY2025	+33% – +36%	New
Nov 4, 2025	revenue	FY2025	$87.00M – $89.00M	New
Aug 5, 2025	revenue guidance growth	FY2025	+30% – +34%	Raised
Aug 5, 2025	revenue guidance	FY2025	$85.00M – $88.00M	Raised
May 8, 2025	growth	FY2025	+27% – +33%	New
May 8, 2025	revenue guidance	FY2025	$83.00M – $87.00M	Raised
Feb 25, 2025	revenue	FY2025	$81.00M – $85.00M	New
Nov 12, 2024	growth	FY2024	+42% – +43%	New
Nov 12, 2024	revenue	FY2024	$64.20M – $64.70M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.